These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18560219)

  • 21. Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.
    Brouns R; Sheorajpanday R; Kunnen J; De Surgeloose D; De Deyn PP
    Eur Neurol; 2009; 62(1):9-15. PubMed ID: 19407450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
    Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
    Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing the use of outcome measures for patients with low back pain: a survey of New Zealand physical therapists.
    Copeland JM; Taylor WJ; Dean SG
    Phys Ther; 2008 Dec; 88(12):1492-505. PubMed ID: 18849478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gavestinel produces no benefit for stroke patients, study finds.
    Clin Resour Manag; 2001 Nov; 2(11):173-5, 161. PubMed ID: 11727452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The past and future of neuroprotection in cerebral ischaemic stroke.
    Shuaib A; Hussain MS
    Eur Neurol; 2008; 59(1-2):4-14. PubMed ID: 17917451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early hospital arrival improves outcome at discharge in ischemic but not hemorrhagic stroke: a prospective multicenter study.
    Naganuma M; Toyoda K; Nonogi H; Yokota C; Koga M; Yokoyama H; Okayama A; Naritomi H; Minematsu K
    Cerebrovasc Dis; 2009; 28(1):33-8. PubMed ID: 19420920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desmoteplase.
    Paciaroni M; Medeiros E; Bogousslavsky J
    Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement properties of the National Institutes of Health Stroke Scale for people with right- and left-hemisphere lesions: further analysis of the clomethiazole for acute stroke study-ischemic (class-I) trial.
    Millis SR; Straube D; Iramaneerat C; Smith EV; Lyden P
    Arch Phys Med Rehabil; 2007 Mar; 88(3):302-8. PubMed ID: 17321821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cerebral ischemia--challenges and perspectives].
    Baron JC
    Therapie; 2002; 57(6):531-9. PubMed ID: 12666260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in stroke symptomology knowledge among US midlife women: an analysis of population survey data.
    Lutfiyya MN; Ng L; Asner N; Lipsky MS
    J Stroke Cerebrovasc Dis; 2009; 18(2):150-7. PubMed ID: 19251192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotection in cerebral infarction: the opportunity of new studies.
    Pérez de la Ossa N; Dávalos A
    Cerebrovasc Dis; 2007; 24 Suppl 1():153-6. PubMed ID: 17971651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials.
    Saver JL
    Stroke; 2007 Nov; 38(11):3055-62. PubMed ID: 17916765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemic stroke intervention requires mixed cellular protection of the penumbra.
    Barone FC
    Curr Opin Investig Drugs; 2009 Mar; 10(3):220-3. PubMed ID: 19333878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating acute ischemic stroke.
    Fisher M; Bastan B
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the National Institutes of Health Stroke Scale with disability outcome measures in acute stroke trials.
    Young FB; Weir CJ; Lees KR;
    Stroke; 2005 Oct; 36(10):2187-92. PubMed ID: 16179579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What can we learn from design faults in the Women's Health Initiative randomized clinical trial?
    Tan O; Harman SM; Naftolin F
    Bull NYU Hosp Jt Dis; 2009; 67(2):226-9. PubMed ID: 19583558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection and stroke: time for a compromise.
    Young AR; Ali C; Duretête A; Vivien D
    J Neurochem; 2007 Nov; 103(4):1302-9. PubMed ID: 17727635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
    Cho HJ; Kim YJ
    Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicians' knowledge, attitudes and professional use of RCTs and meta-analyses: a cross-sectional survey.
    De Vito C; Nobile CG; Furnari G; Pavia M; De Giusti M; Angelillo IF; Villari P
    Eur J Public Health; 2009 Jun; 19(3):297-302. PubMed ID: 19129347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.